In Episode 2 of our 'Tea and Talk' podcast, Dr. Rebekah Widdowfield chats with the CEO of Novabiotics, Dr. Deborah O'Neil about the efficacy of creating drugs, how the vaccine development process works, current efforts being made to produce treatments for COVID-19, and how the current pandemic has affected our approach to global production and collaboration.
Subscribe for a new episode every Friday.
The Royal Society of Edinburgh — @news_RSE
Dr. Rebekah Widdowfield — @Rebekah_RSE
Dr. Deborah O'Neil — @debsoneil | @NovaBiotics
Launching the third series of the RSE’s Tea and Talk Podcast, RSE Chief Executive Rebekah Widdowfield chats with RSE Fellows, Talat Yaqoob and Louise...
Welcome back for another series of the Royal Society of Edinburgh's 'Tea & Talk' Podcast; a series of conversations with some of Scotland's leading...
“Good integration is not camps, it’s not aid. It’s people living in flourishing communities where everyone can contribute.” In S03E05 of the RSE Tea...